• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两性霉素 B 载固体脂质纳米粒 (SLNs) 和纳米结构脂质载体 (NLCs):理化性质和固溶状态表征。

Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations.

机构信息

a Faculty of Pharmaceutical Sciences , Chulalongkorn University , Pathumwan , Bangkok , Thailand.

b Faculty of Pharmaceutical Sciences , University of Iceland , Reykjavik , Iceland.

出版信息

Drug Dev Ind Pharm. 2019 Apr;45(4):560-567. doi: 10.1080/03639045.2019.1569023. Epub 2019 Jan 25.

DOI:10.1080/03639045.2019.1569023
PMID:30632399
Abstract

Amphotericin B (AmB) is one of the most effective systemic antifungal agents, but its use is circumscribed by the dose-limiting toxicity of the conventional micellar dispersion formulation, Fungizone. Significantly lesser toxicity is obtained when AmB incorporated into the aqueous dispersion of lipid nanoparticles. The aim of this study was to develop and characterize AmB loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs). NLC differed from SLN by the presence of liquid lipid, glyceryl tri(caprylate/caprate) in the lipid matrix. Various surfactants i.e. tween 20, cremophor RH40, poloxamer 407 (P407) and Myrj 52 were used to stabilize SLN and NLC. The effect of phospholipid incorporated in those lipid dispersions was also determined. Among surfactants tested, only P407 could stabilize AmB lipid dispersions. There was no chemical reaction occurred between AmB and other components that confirmed by Fourier transform infrared spectroscopy (FT-IR) spectra. The differential scanning calorimetry (DSC), hot-stage microscopy (HSM), powder X-ray diffractometry (PXRD) data showed that AmB was molecularly dispersed or in amorphous form in the lipid matrix. The proton nuclear magnetic resonance (H-NMR) results showed that in the presence of phospholipid oil clusters within the lipid matrix are formed. These results indicate that SLN and NLC stabilized by P407 and/or phospholipid as the colloidal carrier for AmB were successfully developed.

摘要

两性霉素 B(AmB)是最有效的系统抗真菌药物之一,但由于常规胶束分散制剂(Fungizone)的剂量限制毒性,其应用受到限制。当两性霉素 B 被包裹在脂质纳米粒的水性分散体中时,可获得显著较少的毒性。本研究旨在开发和表征两性霉素 B 负载的固体脂质纳米粒(SLN)和纳米结构脂质载体(NLC)。NLC 与 SLN 的区别在于脂质基质中存在液体脂质,即甘油三(辛酸/癸酸)。各种表面活性剂,如吐温 20、吐温 40 聚氧乙烯醚(RH40)、泊洛沙姆 407(P407)和 Myrj 52,用于稳定 SLN 和 NLC。还确定了在这些脂质分散体中加入磷脂的效果。在所测试的表面活性剂中,只有 P407 可以稳定两性霉素 B 脂质分散体。傅立叶变换红外光谱(FT-IR)谱证实,两性霉素 B 与其他成分之间没有发生化学反应。差示扫描量热法(DSC)、热台显微镜(HSM)、粉末 X 射线衍射(PXRD)数据表明,两性霉素 B 以分子形式分散或呈无定形形式存在于脂质基质中。质子核磁共振(H-NMR)结果表明,在磷脂存在下,脂质基质内形成了油簇。这些结果表明,由 P407 和/或磷脂稳定的 SLN 和 NLC 作为两性霉素 B 的胶体载体已成功开发。

相似文献

1
Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations.两性霉素 B 载固体脂质纳米粒 (SLNs) 和纳米结构脂质载体 (NLCs):理化性质和固溶状态表征。
Drug Dev Ind Pharm. 2019 Apr;45(4):560-567. doi: 10.1080/03639045.2019.1569023. Epub 2019 Jan 25.
2
Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations.两性霉素 B 载固体脂质纳米粒(SLNs)和纳米结构脂质载体(NLCs):载药量和药物生物利用度特性的影响。
Drug Dev Ind Pharm. 2018 Oct;44(10):1693-1700. doi: 10.1080/03639045.2018.1492606. Epub 2018 Jul 23.
3
Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.载两性霉素 B 的纳米结构脂质载体的优化、稳定化及其眼部给药特性研究。
Int J Pharm. 2019 Dec 15;572:118771. doi: 10.1016/j.ijpharm.2019.118771. Epub 2019 Oct 26.
4
Amphotericin B Loaded Nanostructured Lipid Carriers for Parenteral Delivery: Characterization, Antifungal and In vitro Toxicity Assessment.两性霉素 B 载药纳米结构脂质载体的注射用给药系统:特性、抗真菌活性和体外毒性评价。
Curr Drug Deliv. 2019;16(7):645-653. doi: 10.2174/1567201816666190729145223.
5
Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.使用抗真菌脂质和表面活性剂制备纳米乳剂并进行优化,以增强两性霉素B的局部递送。
Drug Deliv. 2016 Oct;23(8):3101-3110. doi: 10.3109/10717544.2016.1153747. Epub 2016 Mar 8.
6
Topical Amphotericin B solid lipid nanoparticles: Design and development.局部用两性霉素B固体脂质纳米粒:设计与开发
Colloids Surf B Biointerfaces. 2016 Mar 1;139:17-24. doi: 10.1016/j.colsurfb.2015.07.032. Epub 2015 Dec 3.
7
Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.脂质基质对载奥氮平固体脂质纳米粒的药物包封率、体外释放及物理稳定性影响的研究
AAPS PharmSciTech. 2007 Oct 12;8(4):E83. doi: 10.1208/pt0804083.
8
Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.蔗糖酯稳定的固体脂质纳米粒和纳米结构脂质载体。二、负载咪康唑抗真菌药物的纳米粒子分散体及其凝胶制剂的评价。
Nanotechnology. 2014 Mar 14;25(10):105102. doi: 10.1088/0957-4484/25/10/105102. Epub 2014 Feb 14.
9
Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.液固脂质比对用于透皮给药的氟比洛芬固体脂质纳米粒(SLNs)和纳米结构脂质载体(NLCs)特性的影响。
Drug Dev Ind Pharm. 2016 Aug;42(8):1308-14. doi: 10.3109/03639045.2015.1132226. Epub 2016 Jan 20.
10
Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.脂质纳米载体增强免疫抑制大鼠丁香酚的抗真菌活性。
Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):280-8. doi: 10.1016/j.colsurfb.2011.05.030. Epub 2011 May 26.

引用本文的文献

1
A Review of Formulation Strategies for Cyclodextrin-Enhanced Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs).环糊精增强型固体脂质纳米粒(SLNs)和纳米结构脂质载体(NLCs)的制剂策略综述
Int J Mol Sci. 2025 Jul 6;26(13):6509. doi: 10.3390/ijms26136509.
2
A Double-Blind Randomised Clinical Trial of Terbinafine-Nanostructured Lipid Carriers: Should We Anticipate This Strategy for Effective Topical Treatment of Onychomycosis?特比萘芬纳米结构脂质载体的双盲随机临床试验:我们是否应期待这种策略用于甲真菌病的有效局部治疗?
Mycoses. 2025 Jun;68(6):e70076. doi: 10.1111/myc.70076.
3
Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens.
开拓新领域:抗菌肽与纳米技术融合以攻克胃肠道病原体
Small. 2025 Jul;21(26):e2501431. doi: 10.1002/smll.202501431. Epub 2025 May 19.
4
Development of amphotericin B inclusion complex formulation in dissolvable microarray patches for intravaginal delivery.两性霉素B包合物制剂在可溶解微阵列贴片用于阴道给药的研发。
Daru. 2024 Dec 12;33(1):5. doi: 10.1007/s40199-024-00546-7.
5
Quality by design driven development of lipid nanoparticles for cutaneous targeting: a preliminary approach.基于质量源于设计理念驱动的用于皮肤靶向的脂质纳米颗粒开发:一种初步方法。
Drug Deliv Transl Res. 2025 Apr;15(4):1393-1410. doi: 10.1007/s13346-024-01685-9. Epub 2024 Aug 15.
6
One Platform Comparison of Polymeric and Lipidic Nanoparticles for the Delivery of Amphotericin B.用于两性霉素B递送的聚合物纳米颗粒和脂质纳米颗粒的单一平台比较
AAPS PharmSciTech. 2023 Nov 10;24(8):226. doi: 10.1208/s12249-023-02672-y.
7
Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles.使用可生物降解脂质纳米颗粒增强吉非替尼和阿扎胞苷的联合递送用于治疗转移性耐药肺癌
Materials (Basel). 2023 Jul 30;16(15):5364. doi: 10.3390/ma16155364.
8
Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer.优化载吉非替尼的纳米结构脂质载体作为治疗转移性肺癌的生物医学工具。
Molecules. 2023 Jan 3;28(1):448. doi: 10.3390/molecules28010448.
9
Efficient and Reusable Sorbents Based on Nanostructured BN Coatings for Water Treatment from Antibiotics.基于 BN 纳米结构涂层的高效可重复使用吸附剂用于处理水中抗生素。
Int J Mol Sci. 2022 Dec 17;23(24):16097. doi: 10.3390/ijms232416097.
10
Current Applications of Plant-Based Drug Delivery Nano Systems for Leishmaniasis Treatment.基于植物的药物递送纳米系统在利什曼病治疗中的当前应用
Pharmaceutics. 2022 Oct 29;14(11):2339. doi: 10.3390/pharmaceutics14112339.